Airfinity
Airfinity is a London-based, AI-powered predictive analytics company that delivers health intelligence and forecasting across infectious disease, obesity, and cardiometabolic conditions to pharmaceutical companies, governments, and international health organizations via enterprise subscriptions.
- Company typePrivate
- Founded2015
- HeadquartersLondon, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Airfinity does
Airfinity is an independent predictive analytics company, founded in 2015 and headquartered in London, that builds AI-powered health intelligence and forecasting solutions for the pharmaceutical industry, governments, and international health organizations. Its platform combines proprietary epidemiology models, machine learning, and disease-specialist analyst teams to deliver real-time forecasts and commercial intelligence across infectious disease, cardiometabolic/obesity, and adjacent therapy areas. The core product portfolio comprises six products: FRIDA (respiratory infectious disease forecasting), Airfinity Biorisk (biorisk surveillance across 160+ pathogens), Airfinity One ID (infectious disease intelligence used by 9 of the 10 largest pharma providers in infectious disease), Obesity Market Intelligence, CVRM Intelligence and Forecasting, and Nexa (drug and vaccine demand forecasting and simulation). These are supplemented by bespoke services including Second Opinion Forecasts, Competitive Intelligence, and Burden of Disease Modelling.
The company operates an enterprise go-to-market model, selling annual subscriptions via direct field sales with quote-based pricing and dedicated therapy-area analyst support. Its customer base spans pharma and biotech (AstraZeneca, GeoVax), national governments (UK Vaccine Task Force, White House Office of Pandemic Preparedness and Response Policy), international organizations (WHO), and academic institutions (University of Oxford). Revenue is generated through subscription-based analytics solutions layered with custom professional services. Airfinity maintains a globally distributed remote-first workforce of 101–250 employees and has expanded into APAC via a Japan regional office launched in March 2024. A single funding round (amount undisclosed) was disclosed in July 2022.
Airfinity firmographics
Firmographics- Name
- Airfinity
- Legal name
- Airfinity Limited
- Website
- https://airfinity.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Airfinity is a London-based, AI-powered predictive analytics company that delivers health intelligence and forecasting across infectious disease, obesity, and cardiometabolic conditions to pharmaceutical companies, governments, and international health organizations via enterprise subscriptions.
- Ownership category
- akta.pro rank
Where Airfinity is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Airfinity business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Subscription-based Analytics Solutions: Enterprise subscription model for access to predictive analytics platforms including FRIDA, Airfinity One ID, Airfinity Biorisk, Nexa, and CVRM/Obesity intelligence solutions
- Custom Analytics and Consulting: Bespoke analyst support and consulting services providing tailor-made solutions for specific business needs beyond standard offerings
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription pricing - details not publicly disclosed |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Airfinity product offering
Product offeringCore offering
Airfinity operates an AI-powered predictive analytics platform that delivers real-time health intelligence, disease forecasting, and commercial analytics for the life sciences sector. Its core products cover infectious disease surveillance, respiratory disease forecasting, drug and vaccine demand simulation, and cardiometabolic/obesity market intelligence, all built on a proprietary epidemiology engine drawing from over one billion data points across 160+ diseases. Customers are primarily pharmaceutical companies, governments, and global health organizations that subscribe to enterprise analytics solutions or commission bespoke analyst support.
Product overview
Airfinity is an independent predictive analytics company offering a unified platform of AI-powered health intelligence solutions. The core portfolio includes six main products: FRIDA™ for respiratory disease forecasting, Airfinity Biorisk for biorisk surveillance, Airfinity One ID for infectious disease intelligence, Obesity Market Intelligence, CVRM Intelligence and Forecasting for cardiovascular/renal/metabolic diseases, and Nexa for drug and vaccine demand forecasting. These products are complemented by custom analytical services including Second Opinion Forecasts, Competitive Intelligence, and Burden of Disease Modelling. The platform is built on over one billion data points and serves pharma companies, governments, and non-life science organizations across 160+ diseases.
Differentiator
Problem solved
Functional benefit
Brands
- FRIDA: AI-powered forecasts for respiratory infectious disease dynamics, covering influenza, COVID-19, RSV, hMPV, ILI, ARI, and SARI across key global markets.
- Nexa
- Airfinity Biorisk
- Airfinity One ID
Products and services
- FRIDA
Quantifiable outcome
- 9 out of 10 largest pharmaceutical providers within infectious diseases rely on Airfinity One ID
- +2 more outcomes
Companies that use Airfinity
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Airfinity technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature5 records
Airfinity partnerships and signals
Strategic signalScale indicators7 records
Recent moves7 records
Expansion highlights6 records
Airfinity competitors and assessment
Company assessmentDirect peers
- Definitive Healthcare: Definitive Healthcare sells healthcare commercial intelligence and analytics to pharma, medtech, and providers. It is comparable in target customer and product category, though more focused on provider/claims data than disease forecasting.
- Citeline (Informa Pharma Intelligence): Citeline provides pipeline, clinical trial, and commercial intelligence to pharma and biotech, overlapping heavily with Airfinity's One ID, Obesity, and CVRM products. It is one of the closest functional competitors in pharma pipeline intelligence.
- Trinity Life Sciences: Trinity Life Sciences delivers commercial analytics, forecasting, and competitive intelligence to pharma. It directly competes with Airfinity's Second Opinion Forecasts and Competitive Intelligence offerings for the same enterprise pharma buyers.
- Evaluate (Norstella): Evaluate (now part of Norstella) is the long-standing market leader in pharma forecasting and consensus sales analytics. It directly competes with Airfinity's commercial forecasting and pipeline intelligence offerings across the same pharma customer base.
Emerging players
- Health Catalyst: Health Catalyst provides data and analytics infrastructure for health systems and life sciences. While more provider-focused, its life sciences analytics and outcomes products intersect with Airfinity's CVRM and disease burden offerings.
- Metabiota (now part of Ginkgo Bioworks): Metabiota specialized in infectious disease risk analytics and outbreak intelligence, comparable to Airfinity's Biorisk product. Its integration into Ginkgo Bioworks repositioned it, but it remains a thematic peer in pandemic risk analytics.
- ZS Associates: ZS Associates combines consulting with proprietary pharma analytics and AI-driven sales/forecasting tools. It targets the same pharma commercial leaders as Airfinity and increasingly overlaps in AI-based demand forecasting.
Broad incumbents
- GlobalData: GlobalData provides industry intelligence across pharma, healthcare, and consumer verticals, including disease forecasts and pipeline analysis. It overlaps with Airfinity's commercial forecasting and disease intelligence offerings.
- IQVIA: IQVIA is the largest contract research and healthcare data analytics firm globally. It serves the same pharma and government customers with a much broader portfolio, competing with Airfinity on commercial forecasting and real-world evidence.
- Clarivate: Clarivate offers pharma and biotech intelligence (e.g., Cortellis, Drug Launch) to overlapping enterprise customers. It competes indirectly with Airfinity's pipeline and competitive intelligence products as part of a much wider IP and analytics portfolio.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Airfinity social profiles
Digital presenceAirfinity financial estimates
Financial estimateRevenue estimate
Valuation estimate
Airfinity leadership team
Management profileNumber of profiles
Profiles10 records
Airfinity subsidiaries and ownership
Company hierarchySubsidiaries1 record
Airfinity funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Airfinity M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Airfinity
What does Airfinity do?
Airfinity operates an AI-powered predictive analytics platform that delivers real-time health intelligence, disease forecasting, and commercial analytics for the life sciences sector. Its core products cover infectious disease surveillance, respiratory disease forecasting, drug and vaccine demand simulation, and cardiometabolic/obesity market intelligence, all built on a proprietary epidemiology engine drawing from over one billion data points across 160+ diseases. Customers are primarily pharmaceutical companies, governments, and global health organizations that subscribe to enterprise analytics solutions or commission bespoke analyst support.
Is Airfinity a public or private company?
Airfinity is a private company. It is classified as venture growth investor backed and is currently operating.
When was Airfinity founded?
Airfinity was founded in 2015. It employs 101 to 250 people.
Where is Airfinity based?
Airfinity is headquartered in London, United Kingdom, in the Europe region.
How does Airfinity make money?
Two revenue lines are on record. Subscription-based Analytics Solutions are the primary driver. The others are custom Analytics and Consulting.
Who are Airfinity's main competitors?
Direct peers on record are Definitive Healthcare, Citeline (Informa Pharma Intelligence), Trinity Life Sciences and Evaluate (Norstella). Emerging players are Health Catalyst, Metabiota (now part of Ginkgo Bioworks) and ZS Associates. Broad incumbents are GlobalData, IQVIA and Clarivate.
Does Airfinity have an API?
No public API is recorded for Airfinity.